Background and objectives: Esophagogastroduodenoscopy is a valuable diagnostic method for the treatment of various diseases that has found a wonderful application in recent years. Yet, controlling patients' pain and nausea is a fundamental factor to increase patient satisfaction, reduce patients' discomfort, and increase the patient's cooperation. Therefore, this study aimed to assess the efficacy of Eutectic Mixture of Local Anesthesia (EMLA) cream and gel, as a topical pharyngeal anesthetic on patients' pharyngeal pain, nausea/vomiting, and satisfaction, in comparison with lidocaine gel and spray and placebo.
Introduction
The use of esophagogastroduodenoscopy (EGD) has widely extended in diagnosis and treatment of various gastrointestinal (GI) pathologies recently; yet, like any other medical intervention, EGD is also not complication-free (Rondonotti et al., 2005) . Patients undergoing EGD frequently complain of stress, pain, and nausea/vomiting, which significantly affect patient satisfaction, comfort, and cooperation; thus, various methods have been used to control pain during and after EGD (Thomson, Andrew, & Jones, 2010) , including intravenous (IV) and local anesthetic and analgesic drugs (Bell, 2002; Hickle, 2005) .
Although IV sedation increases patient satisfaction (Trevisani et al., 2004) , studies have indicated downward trend in its use due to fatal cardiopulmonary complications (Mulcahy et al., 2001) . Therefore, topical pharyngeal anesthetics, like benzocaine and lidocaine, have been used to reduce patients' pain and decrease the required dose of IV sedation (Hedenbro, Ekelund, Jansson, & Lindblom, 1992; Ristikankare, Hartikainen, Heikkinen, & Julkunen, 2004) . Although review studies have indicated the effectiveness of local anesthetics in increasing patients' tolerance and ease of endoscopy (Evans, Saberi, Kim, Elta, & Schoenfeld, 2006) , the precise efficacy and complication of each drug has to be evaluated (Thomson et al., 2010) , as some have been recognized to induce some complications; for instance, life-threatening methemoglobinemia has be reported to be induced by local benzocaine and prilocaine (Guay, 2009; Kane, Hoehn, Behrenbeck, & Mulvagh, 2007) .
Eutectic Mixture of Local Anesthesia (EMLA) (containing 25 mg/ml of lidocaine and prilocaine) has recently been used as an effective topical anesthetic in various fields, including pediatric dermatologic local anesthesia (Chen & Cunningham, 2001) , oropharyngeal topical anesthesia in bronchoscopy (Sohmer, Bryson, Bencze, & Scharf, 2003) and fiberoptic intubation (Larijani et al., 2000) , and mucosal anesthesia (Barcohana, Duperon, & Yashar, 2003; McMillan, Walshaw, & Meechan, 2000) . Dermatologic pediatric practices have established some side effects for EMLA including transient skin blanching, erythema, urticaria, allergic contact dermatitis, and purpura (Neri, Savoia, Guareschi, Medri, & Patrizi, 2005) . But EMLA has rarely been used to reduce patients' pain during and after EGD and the thorough details on its efficacy, benefits, and side effects in EGD have to be elucidated.
As long as EGD is associated with increased patients' anxiety (Jones et al., 2004) , which is counter-related to patient satisfaction and cooperation (Mahajan, Johnson, & Marshall, 1997) , studies have recommended assessing the patients with a higher precision for evaluation of the efficacy of topical anesthetics.
Therefore, this study aimed to assess the efficacy of EMLA as a topical pharyngeal anesthetic on patients' pharyngeal pain, nausea/vomiting, and satisfaction.
Materials and Methods

Patient Selection
This double-blind randomized clinical trial (RCT) recruited patients who referred for upper gastro-intestinal endoscopy to the Endoscopy Center of Hajar hospital, Shahrekord city, Iran from May to September 2006. According to the calculated sample size, 150 patients were randomly recruited into the study.
Study Design
This clinical trial was double-blind and the physician performing the endoscopy, the person administering local anesthesia, and the patient were unaware of the type of the anesthetic used. The inclusion criteria comprised of patients' age over 12 years, patients undergoing non-emergency (outpatient) upper gastrointestinal endoscopy, patients with no previous experience of emergency or elective upper gastrointestinal endoscopy, and consent to undergo endoscopy and participate in the research. Exclusion criteria included patients with current acute gastrointestinal bleeding. After patient selection, a precise medical history was taken from all patients to assess the inclusion/exclusion criteria in patients and their demographic data, including age and gender was recorded and the selected patients were ultimately randomly assigned to five groups: Group A received 5 g EMLA cream (manufactured by Astrazenca company, UK), group B received EMLA gel, group C received lidocaine gel, group D received placebo gel (Plain lubricant gel as placebo gel), and group E received 3 puffs of 1% lidocaine spray on the posterior part of the tongue 5 minutes before endoscopy. Placebo gel was made of a carboxymethyl cellulose sodium salt and was similar in appearance and taste.
After upper gastrointestinal endoscopy, patient satisfaction was assessed by GHAA-9 questionnaire (Group Health Association of America), recommended by American Society of Gastrointestinal Endoscopy (Johanson et al., 2000) that has also been used in Iranian studies (Rahimian, 2008) . The content validity of the questionnaire was confirmed by our specialists and test-retest was used to assess the reliability of the questionnaire and coefficient correlation was calculated at 0.7 for the questionnaire's reliability. The questionnaire has 15 questions with a score of 1-5 for each question, resulting in a total score of 15-75. Patients' pain and discomfort was assessed by a checklist based on Likert scale, in which 5=very good, 4=good, 3=average, 2=bad, and 1=very bad. Number of nausea/vomiting episodes of patients was also recorded.
Statistical Methods
The collected data was entered into SPSS software version 18.0. Continuous variables were reported as mean and standard deviation. Descriptive data was reported as frequency and percentage. As data was not normally distributed, non-parametric statistical tests were used for analysis of the difference in groups. Chi-square test was used to compare the patient satisfaction, pain and discomfort among groups and Mann-Whitney test was used to compare the mean episodes of nausea/vomiting among groups. P-values less than 0.05 have been considered as statistically significant.
Ethical Considerations
The protocol of the study was submitted in IRCT by the code IRCT201509136480N9 and was approved by www.ccsenet.org/gjhs Global Journal of Health Science Vol. 9, No. 1; 2017 Ethics Committee of Shahrekord University of Medical Sciences. The protocol and objectives of the study were explained to all patients and informed consent was obtained from all participants and those who were not willing to enter the study or continue the study at any phase were excluded from the study.
Results
The mean age of patients was 44.1±16.8 and 76 (50.7%) of participants were male and 74 (49.3%) were female. The demographic characteristics of patients in each group is demonstrated in Table 1 . There was no significant difference regarding age and gender among the five groups (P=0.849 and 0.924, respectively). Patients' throat pain and discomfort was marked as very good by 83.3% of patients in group A, 50% in group B, 50% in group C, 36.7% in group D, and 46.7% in group E. Throat pain and discomfort during and after endoscopy was statistically different between groups (P<0.05). The frequency of the scores that the patients had given to the amount of pain and discomfort is demonstrated as Table 3 . 
Discussion
The results of the current RCT demonstrated that the throat and pharyngeal pain and discomfort and nausea/vomiting during and after endoscopy was significantly lower in EMLA cream group (P<0.05), which demonstrated the efficacy of EMLA cream and its superiority to lidocaine gel and spray.
The use of topical anesthetics in EGD has been recently proposed and different topical anesthetics have been investigated. Soma and colleagues have compared topical administration of 5 mL of 2% lidocaine hydrochloride with placebo and concluded lower anxiety and discomfort in swallowing the endoscope in the intervention group, especially in patients under 40 years (Soma et al., 2001 ). Leitch and colleagues have compared lidocaine spray to placebo and have suggested higher patient acceptability and tolerance in lidocaine group (Leitch, Wicks, El Beshir, Ali, & Chaudhury, 1993) . Hedenbro et al have also endorsed less throat discomfort and higher ease of examination by 80-120 mg topical lidocaine, compared to placebo (Hedenbro et al., 1992) . Various studies have also demonstrated severe life-threatening complications, like methemoglobinemia, for benzocaine and prilocaine (Guay, 2009; Kane et al., 2007) .
Some studies have compared the efficacy of IV and topical anesthetics. Ristikankare et al have compared IV midazolam with lidocaine pharyngeal spray and placebo and have concluded that the topical pharyngeal anesthesia made endoscopy technically easier, but could not have a positive influence on patient tolerance, compared to IV sedation (Ristikankare et al., 2004) .
EMLA cream has been widely used in different procedures (Barcohana et al., 2003; Chen & Cunningham, 2001; Larijani et al., 2000; McMillan et al., 2000; Sohmer et al., 2003) and its efficacy and safety have been proven in different clinical trials (Friedman, Mafong, Friedman, & Geronemus, 2001 ), but has rarely been used in reducing patients' pain during EGD. Fanurik et al have also established the efficacy of combination of distraction techniques with EMLA cream on children's distress during and after IV insertion (Fanurik, Koh, & Schmitz, 2000) . Randell and colleagues have also compared efficacy of lignocaine spray, gel, and swabs with EMLA cream in fibreoptic airway endoscopy and have determined EMLA cream as the least unpleasant agent and lignocaine spray and gel as better anesthetic agent in nasal mucosa, causing increase in arterial pressure (Randell, Yli-Hankala, Valli, & Lindgren, 1992) . As there are few studies assessing the efficacy of EMLA cream as local sedation in EGD, further studies have to be conducted to determine its precise efficacy and side effects.
In the present study, patient satisfaction score was not statistically different between EMLA, lidocaine, and placebo (P>0.05), which might be resulted from inadequacy of the GHAA-9 questionnaire in assessing all factors affecting patient satisfaction (Yacavone et al., 2001) , thus, we have added pain assessment to the questionnaire to be able to achieve more precise results, as far as pain is not included in GHAA-9 questionnaire. In addition, it might be due to the fact that patient satisfaction can be affected by various factors, such as personnel's manner and skill (Ko, Zhang, Telford, & Enns, 2009) , patients' information and preparedness prior to the intervention (Shepherd, Bowman, Hancock, Anglin, & Hewett, 2000; van Vliet, Grypdonck, van Zuuren, Winnubst, & Kruitwagen, 2004) , and some demographic characteristics of patients like age, gender, gag reflex, and baseline anxiety (Campo et al., 1999; Trevisani et al., 2004) , however, we tried to match or exclude some important factors established to have controversial effects on patient satisfaction in the current study like previous experience of EGD (Drossman et al., 1996; Rabeneck, Wristers, Souchek, & Ambriz, 2003) . Although some other questionnaires have been proposed (Peña, Mardini, & Nickl, 2005) , GHAA-9 questionnaire seems to be the most valid and reliable assessment tool for patient satisfaction (del Río, Baudet, Fernandez, Morales, & del Rosario Socas, 2007) . It might also be due to the nature of EGD, as swallowing the endoscope reduces patients' tolerance and causes discomfort for patients (Walmsley & Montgomery, 1998) .
Due to the limited number of clinical trials assessing topical anesthetics in EGD, especially EMLA cream, it is strongly suggested that further studies investigate the precise efficacy and side effects of EMLA cream in EGD.
Beside the strengths of the current study, including the randomized nature of the trial, controlling the confounding factors, assessment of patients' throat pain and discomfort and nausea/vomiting beside GHAA-9 questionnaire, which has scarcely been evaluated in studies, our study was also not free from limitations. Due to the fact that various factors affect patient satisfaction and GHAA-9 questionnaire might be insufficient, it would be better if patient anxiety was simultaneously evaluated by a valid questionnaire like State-Trait Anxiety Index, as anxiety is closely related to patient satisfaction. 
Conclusion
Although some studies have concluded that topical anesthetics should be used as a premedication in inducing anesthesia in EGD and is not sufficient (Randell et al., 1992) , review studies have indicated their efficacy (Thomson et al., 2010) , similarly, the current study could prove the efficacy of EMLA cream, as a topical pharyngeal anesthetic, on reducing patients' pain and discomfort and nausea/vomiting during and after EGD, although EMLA was not significantly different from lidocaine regarding patient satisfaction.
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